In myeloma patients, diverse angiogenic factors such as VEGF, endoglin, TNF-alpha, HGF, FGF, endostatin, thrombospondin-1 (TSP-1), and angiostatin factor are already well studied in peripheral blood and bone marrow [18, 30]. The gene discussed is ENG; the disease is plasma cell myeloma.